Debra Yu - 04 May 2022 Form 4 Insider Report for LianBio (LIANY)

Role
President & Chief Strategy Officer
Signature
By: /s/ Angela Chen, Attorney-in-Fact
Issuer symbol
LIANY
Transactions as of
04 May 2022
Net transactions value
+$1,710,000
Form type
4
Filing time
06 May 2022, 16:15:15 UTC
Previous filing
27 Apr 2022
Next filing
12 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIAN Ordinary Shares Options Exercise $1,710,000 +1,000,000 $1.71 1,000,000 04 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIAN Stock Option (Right to Buy) Options Exercise $0 -1,000,000 -50% $0.000000 999,947 04 May 2022 Ordinary Shares 1,000,000 $1.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the shares underlying the option vested and became exercisable on January 1, 2020; 1/3 of the shares underlying the option vested and became exercisable on October 1, 2020 and 1/3 of the shares underlying the option vested and became exercisable on October 1, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Remarks:

President & Chief Strategy Officer